共 162 条
[1]
Humphreys K(2022)Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission Lancet 399 555-604
[2]
Shover CL(2021)The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis Curr Opin Psychiatry 34 344-350
[3]
Andrews CM(2021)The changing opioid crisis: development, challenges and opportunities Mol Psychiatry 26 218-233
[4]
Bohnert ASB(2023)Xylazine—medical and public health imperatives N Engl J Med 388 2209-2212
[5]
Brandeau ML(2023)Promises and perils of the FDA's over-the-counter naloxone reclassification Lancet Reg Health Am 23 295-313
[6]
Caulkins JP(2023)The first drug-related death associated with xylazine use in the UK and Europe J Forensic Leg Med 97 400-402
[7]
Ciccarone D(1988)Xylazine—a review of its pharmacology and use in veterinary medicine J Vet Pharmacol Ther 11 1-8
[8]
Volkow ND(1998)Xylazine toxicity–literature review and report of two cases J Forensic Sci 43 892-901
[9]
Blanco C(2014)Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature Forensic Sci Int 240 911-917
[10]
Gupta R(2022)Xylazine poisoning: a systematic review Clin Toxicol (Phila) 60 290-293